ACE2 and Parkinson disease: Core Analysis revealed the neuroinflammation signaling pathway (NISP) to be one of the principal signaling pathways involved and SNCA as the top upstream controller associated with both COVID-19 and PD. A network connectivity pathway map of the downstream effects of COVID-19 revealed that ACE2 blocking upregulates SNCA expression, potentially accelerating PD progression.